PMID: 9431946Feb 12, 1998Paper

In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens

Journal of Clinical Microbiology
A Espinel-Ingroff

Abstract

The in vitro antifungal activity of a new triazole derivative, voriconazole, was compared with those of itraconazole and amphotericin B against 67 isolates of Aspergillus flavus, Aspergillus fumigatus, Bipolaris spp., Fusarium oxysporum, Fusarium solani, Pseudallescheria boydii, Rhizopus arrhizus, Blastomyces dermatitidis, Histoplasma capsulatum, and Sporothrix schenckii. The in vitro activities of voriconazole were also compared with those of amphotericin B, fluconazole, and itraconazole against 189 isolates of emerging and common yeast pathogens of Blastoschizomyces capitatus, Candida (13 species), Cryptococcus neoformans, Hansenula anomala, Rhodotorula rubra, Saccharomyces cerevisiae, Sporobolomyces salmonicolor, and Trichosporon beigelii. MICs were determined according to a procedure under evaluation by the National Committee for Clinical Laboratory Standards (NCCLS) for broth microdilution testing of filamentous fungi and by the NCCLS M27-A broth microdilution method for yeasts. The in vitro activities of voriconazole were similar to or better than those of itraconazole and amphotericin B against Aspergillus spp., Fusarium spp., and P. boydii as well as against B. dermatitidis and H. capsulatum. The activities of voriconaz...Continue Reading

References

Dec 11, 1992·Journal of Clinical Microbiology·A Espinel-IngroffM G Rinaldi
Sep 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·V J FraserW C Dunagan
Mar 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E Anaissie
Jul 1, 1991·The Journal of Antimicrobial Chemotherapy·R J Hay
Apr 1, 1988·Clinical Microbiology Reviews·R A Fromtling
Jun 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W R Jarvis
Apr 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·T J WalshP A Pizzo
Aug 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S H Khoo, D W Denning
Feb 1, 1994·Diagnostic Microbiology and Infectious Disease·H DonabedianN Budd
Oct 1, 1995·Clinical Microbiology Reviews·K C Hazen

❮ Previous
Next ❯

Citations

Apr 4, 2000·Bone Marrow Transplantation·B ErerG Izzi
Sep 7, 2000·Leukemia & Lymphoma·I Pérez-SanchezT Pintado
Oct 20, 2001·The Pediatric Infectious Disease Journal·M Wellington, F Gigliotti
Sep 29, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R AllyUNKNOWN Esophageal Candidiasis Study Group
Sep 15, 2001·Medical Mycology·M R McGinnisD W Warnock
Feb 7, 2002·Expert Opinion on Pharmacotherapy·Francisco Marty, Eleftherios Mylonakis
Apr 20, 2002·Current Opinion in Infectious Diseases·Melanie W PoundJohn R Perfect
Apr 15, 2003·Mycoses·M Ruhnke
Nov 18, 2003·British Journal of Clinical Pharmacology·Lynn PurkinsAnitra Fielding
Nov 18, 2003·British Journal of Clinical Pharmacology·Lynn PurkinsDon Nichols
Jan 8, 2004·Journal of Chemotherapy·W J Steinbach, J R Perfect
Oct 25, 2003·Antimicrobial Agents and Chemotherapy·Eric DannaouiPaul E Verweij
Nov 18, 2003·British Journal of Clinical Pharmacology·Lynn PurkinsDon Nichols
Nov 18, 2003·British Journal of Clinical Pharmacology·Lynn PurkinsDon Nichols
Dec 31, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sanjay G RevankarMichael G Rinaldi
Jul 22, 2004·Progress in Transplantation : Official Publication, North American Transplant Coordinators Organization ... [et Al.]·Loretta M ChiuJeong M Park
Oct 27, 2004·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Feb 8, 2005·The Journal of Antimicrobial Chemotherapy·Alicia Gomez-LopezManuel Cuenca-Estrella
Oct 16, 2004·Expert Review of Anti-infective Therapy
Mar 15, 2005·Scandinavian Journal of Infectious Diseases·Olaf BurkhardtTobias Welte
Jan 5, 2006·Transplant Infectious Disease : an Official Journal of the Transplantation Society·A G FreifeldA C Kalil
Aug 10, 2005·Expert Opinion on Pharmacotherapy·Gianna ZuccottiDavid M Weinstock
Jul 20, 2006·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Laila SahraouiJean-Eudes Fontan
May 31, 2006·Expert Opinion on Investigational Drugs·George Aperis, Eleftherios Mylonakis
Nov 8, 2006·Antimicrobial Agents and Chemotherapy·Andres PascualOscar Marchetti
Apr 13, 2007·Transplant Infectious Disease : an Official Journal of the Transplantation Society·G M GauthierD R Andes
Jan 24, 2007·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·JoAnn A GiaconiEduardo C Alfonso
Nov 21, 2007·Journal of Clinical Pharmacology·Ping LiuAmarnath Sharma
Mar 25, 2008·Therapeutics and Clinical Risk Management·Javier PemánMiguel Gobernado
Jul 1, 2008·Expert Review of Anti-infective Therapy·Hiroto Narimatsu, Masahiro Kami
Dec 2, 2009·Expert Opinion on Drug Metabolism & Toxicology·George R Thompson, James S Lewis
Mar 27, 2010·Mycoses·J García-SuárezC Burgaleta
Jan 5, 2011·American Journal of Respiratory and Critical Care Medicine·Andrew H LimperUNKNOWN American Thoracic Society Fungal Working Group
Oct 19, 2012·Mycopathologia·Graziella Hanna PereiraMarcia de Souza Carvalho Melhem
Feb 7, 2013·Antimicrobial Agents and Chemotherapy·David A Stevens
Mar 31, 2015·Spine·Devin GaneshFrank Eismont

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.